Position in GMAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$136,672,150
+$3,184,208 QoQ
Shares Held
4,975,324
0.0% QoQ
Ownership
0.809%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#6
of 289 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,519,535,758 across 72 Biotechnology names. GMAB ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
738,378 | $366,774,503 | |
| 2 | INCY |
Incyte Corp
|
2,744,958 | $311,168,438 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
393,685 | $245,478,344 | |
| 4 | EXEL |
Exelixis, Inc.
|
4,365,926 | $237,550,033 | |
| 5 | GMAB |
Genmab A/S
This page
|
4,975,324 | $136,672,150 | |
| 6 | RPRX |
Royalty Pharma plc
|
2,435,341 | $136,549,569 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
1,704,623 | $133,420,842 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
249,758 | $71,173,537 |
All Filings in GMAB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,672,150 | 4,975,324 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $133,487,942 | 4,975,324 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $153,324,186 | 4,978,058 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $111,735,073 | 3,643,139 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $71,367,449 | 3,454,378 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $26,813,086 | 1,369,412 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $635,282 | 30,440 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $340,989 | 93,628 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $940,088 | 37,409 | Shares | Defined | 2024-08-14 | |
| 2023-03-31 | $38,308,766 | 1,014,533 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $74,386,096 | 1,755,217 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $47,729,950 | 1,485,526 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $42,065,420 | 1,294,719 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $31,448,415 | 869,221 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $20,979,419 | 530,319 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,690,446 | 427,699 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $391,968 | 9,600 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,270,951 | 99,633 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $15,682,562 | 385,700 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $17,557,972 | 479,595 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $24,731,871 | 729,769 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $14,373,219 | 678,302 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||